ArticleBritish journal of cancer2013

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL.

A Meijer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.